Questcor - Best Pharma Stocks on 2007
Company: Questcor
Starting stock price: $1.45
Ending stock price: $5.77
Percent Change: 298%
Details: Union City, CA-based Questcor Pharmaceuticals develops and commercializes novel CNS-focused therapeutics. With 70 workers and a market cap of $366 million, the company's stock increased an impressive 298% in 2007. It's marketed products include Doral for insomnia and H.P. Acthar Gel.
More stories about Questcor
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: